LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.15-1.28 for the period, compared to the consensus earnings per share estimate of $1.16. The company issued revenue guidance of $187.1-193.1 million, compared to the consensus revenue estimate of $176.11 million. LeMaitre Vascular also […]
LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its second quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.30-0.35 for the period, compared to the consensus estimate of $0.31. The company issued revenue guidance of $47.1-49.5 million, compared to the consensus revenue estimate of $44.94 million. LeMaitre Vascular also updated […]
LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.15-1.28 for the period, compared to the consensus estimate of $1.16. The company issued revenue guidance of $187.1-193.1 million, compared to the consensus revenue estimate of $176.11 million. LeMaitre Vascular also updated its […]
LeMaitre Vascular (NASDAQ:LMAT – Get Rating) updated its FY 2023 earnings guidance on Wednesday. The company provided EPS guidance of $1.14-$1.28 for the period, compared to the consensus EPS estimate of $1.16. The company issued revenue guidance of $187.10 million-$193.10 million, compared to the consensus revenue estimate of $176.11 million. LeMaitre Vascular also updated its […]
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) – Equities research analysts at KeyCorp upped their Q3 2023 earnings estimates for shares of LeMaitre Vascular in a note issued to investors on Tuesday, May 2nd. KeyCorp analyst M. Mishan now expects that the medical instruments supplier will earn $0.27 per share for the quarter, up from […]